Shares of Raia Drogasil S.A. (OTCMKTS:RADLY – Get Free Report) dropped 6.9% on Thursday . The company traded as low as $3.9550 and last traded at $3.9550. Approximately 150 shares were traded during trading, a decline of 99% from the average daily volume of 17,999 shares. The stock had previously closed at $4.25.
Analysts Set New Price Targets
Separately, Zacks Research upgraded Raia Drogasil to a “hold” rating in a research report on Thursday, April 9th. One analyst has rated the stock with a Hold rating, According to MarketBeat, the company currently has a consensus rating of “Hold”.
View Our Latest Stock Report on RADLY
Raia Drogasil Price Performance
Raia Drogasil Company Profile
Raia Drogasil SA is a leading Brazilian retail pharmacy operator, offering a comprehensive range of prescription and over-the-counter medications, health and wellness products, personal care and beauty items, as well as a selection of convenience goods. The company’s network of stores operates under the Raia and Drogasil banners, serving diverse consumer needs across major urban centers. Complementary services include in-store prescription dispensing, compounding pharmacies and health screening programs such as blood pressure and glucose monitoring.
The company was formed in 2011 through the merger of two established Brazilian pharmacy chains, Drogasil and Droga Raia, each with origins dating back several decades.
See Also
- Five stocks we like better than Raia Drogasil
- YETI Rallies After Earnings Beat and Raised Outlook
- How the 3 Leading Quantum Firms Stack Up After Q1 Earnings
- Cisco’s Vertical Rally May Still Be in the Early Innings
- Amazon vs. Alibaba: One Is Clearly The Better Value Play right Now
Receive News & Ratings for Raia Drogasil Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Raia Drogasil and related companies with MarketBeat.com's FREE daily email newsletter.
